{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T06:22:21Z","timestamp":1789539741015,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T00:00:00Z","timestamp":1778025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Achieving target low-density lipoprotein cholesterol (LDL-C) levels in patients with atherosclerotic cardiovascular disease (ASCVD) frequently requires combination lipid-lowering therapy. Single-pill combination (SPC) regimens may improve adherence compared with free-dose combinations (FDC) in real-world clinical practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This retrospective observational study included 450 ASCVD patients with baseline LDL-C levels of 70\u2013189\u00a0mg\/dL who were followed in cardiology outpatient clinics between January 2023 and December 2024. Patients received atorvastatin\u2013ezetimibe either as a single-pill combination (SPC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009392) or as a free-dose combination (FDC,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200958). Primary endpoints were LDL-C reduction and treatment adherence (\u2265\u200980% of prescribed doses). Secondary endpoints included LDL-C target attainment and adverse events. Non-parametric tests and chi-square\/Fisher\u2019s exact tests were used for statistical analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      At 1 month, LDL-C levels were significantly lower in the SPC group compared with the FDC group (90.6 vs. 119\u00a0mg\/dL;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005), and adherence was higher (89.8% vs. 70.7%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). At 4 months, LDL-C levels were comparable between groups, while continuous adherence remained significantly higher in the SPC group (86% vs. 69%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001). A higher proportion of SPC-treated patients achieved LDL-C\u2009&lt;\u2009100\u00a0mg\/dL at 1 month (81.9% vs. 67.2%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.009).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this real-world ASCVD cohort, SPC therapy with atorvastatin and ezetimibe was associated with superior adherence and comparable lipid-lowering efficacy despite lower statin doses. Fixed-dose combination strategies may represent an effective approach to optimize adherence and cardiovascular risk management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12944-026-02950-1","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T13:14:22Z","timestamp":1778073262000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy and safety of combination therapy with statin and ezetimibe in patients failing to achieve target LDL levels at cardiology outpatient clinics in Turkey (COM-TR-OLDL): a real-world observational study"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-6158","authenticated-orcid":false,"given":"Ay\u015fe","family":"\u00c7olak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2422-9363","authenticated-orcid":false,"given":"Zeynep","family":"Kumral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4204-0599","authenticated-orcid":false,"given":"\u00d6nder","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-3651","authenticated-orcid":false,"given":"Ay\u015feg\u00fcl","family":"\u00dclgen Kunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2774-7345","authenticated-orcid":false,"given":"Ali Nizami","family":"Elmas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-6707","authenticated-orcid":false,"given":"\u00d6mer","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6080-6335","authenticated-orcid":false,"given":"Medeni","family":"Karaduman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4970-0345","authenticated-orcid":false,"given":"Naci","family":"Babat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7775-2751","authenticated-orcid":false,"given":"Umut","family":"Uyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0022-8032","authenticated-orcid":false,"given":"Nurcemal","family":"\u015eent\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6010-1319","authenticated-orcid":false,"given":"Sebahat","family":"Tekeli \u015eeng\u00fcl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6209-1732","authenticated-orcid":false,"given":"Sefa Erdi","family":"\u00d6m\u00fcr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6437-0903","authenticated-orcid":false,"given":"\u015eahbender","family":"Ko\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8527-3769","authenticated-orcid":false,"given":"Mehmet Ali","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0115-1519","authenticated-orcid":false,"given":"Samet","family":"Uysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2456-3206","authenticated-orcid":false,"given":"Cennet","family":"Y\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0392-6346","authenticated-orcid":false,"given":"Emre","family":"Asilt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8470-1928","authenticated-orcid":false,"given":"Tuncay","family":"G\u00fczel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5016-5511","authenticated-orcid":false,"given":"Fahri","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2271-2549","authenticated-orcid":false,"given":"Alk\u0131m Ate\u015fli","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4102-444X","authenticated-orcid":false,"given":"Emrah","family":"Ye\u015fil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5351-6866","authenticated-orcid":false,"given":"Fuat","family":"Bice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0547-6510","authenticated-orcid":false,"given":"Cansu","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1880-5280","authenticated-orcid":false,"given":"Murat G\u00f6khan","family":"Yerlikaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7768-2562","authenticated-orcid":false,"given":"L\u00fctf\u00fc","family":"A\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-3021","authenticated-orcid":false,"given":"Melisa","family":"U\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4818-9044","authenticated-orcid":false,"given":"Murat","family":"\u00c7ak\u0131r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9810-6038","authenticated-orcid":false,"given":"\u00d6mer","family":"Uluuysal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2514-5516","authenticated-orcid":false,"given":"Afag","family":"\u00d6zy\u0131ld\u0131z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3530-9502","authenticated-orcid":false,"given":"Yusuf Demir","family":"Ozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0838-2037","authenticated-orcid":false,"given":"Tolga","family":"Kunak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3426-1212","authenticated-orcid":false,"given":"Sel\u00e7uk","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-6934","authenticated-orcid":false,"given":"\u00d6zkan","family":"Karaca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0379-7812","authenticated-orcid":false,"given":"\u00d6zkan","family":"Kayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5516-3980","authenticated-orcid":false,"given":"Khayal","family":"Mirzayev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3657-9045","authenticated-orcid":false,"given":"\u0130lke","family":"\u00c7elikkale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-9294","authenticated-orcid":false,"given":"Emine Buket","family":"K\u0131rda\u011f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8156-2675","authenticated-orcid":false,"given":"Mehdi","family":"Zoghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-4063","authenticated-orcid":false,"given":"As\u0131m Oktay","family":"Ergene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,6]]},"reference":[{"issue":"32","key":"2950_CR1","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","volume":"38","author":"BA Ference","year":"2017","unstructured":"Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, Hegele RA, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. Eur Heart J. 2017;38(32):2459\u201372.","journal-title":"Eur Heart J"},{"issue":"9753","key":"2950_CR2","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","volume":"376","author":"C Baigent","year":"2010","unstructured":"Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet. 2010;376(9753):1670\u201381.","journal-title":"Lancet"},{"issue":"36","key":"2950_CR3","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, et al. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45(36):3415\u2013537.","journal-title":"Eur Heart J"},{"issue":"11","key":"2950_CR4","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1093\/eurjpc\/zwaa047","volume":"28","author":"KK Ray","year":"2021","unstructured":"Ray KK, Molemans B, Schoonen WM, Giovas P, Bray S, Kiru G, Murphy J, et al. EU-wide cross-sectional observational study of lipid-modifying therapy use in secondary and primary care: the DA VINCI study. Eur J Prev Cardiol. 2021;28(11):1279\u201389.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"2950_CR5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12944-019-1099-z","volume":"18","author":"PP Toth","year":"2019","unstructured":"Toth PP, Granowitz C, Hull M, Anderson A, Philip S. Long-term statin persistence is poor among high-risk patients with dyslipidemia: a real-world administrative claims analysis. Lipids Health Dis. 2019;18(1):175.","journal-title":"Lipids Health Dis"},{"issue":"5","key":"2950_CR6","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1111\/jch.13272","volume":"20","author":"LP Du","year":"2018","unstructured":"Du LP, Cheng ZW, Zhang YX, Li Y, Mei D. The impact of fixed-dose combination versus free-equivalent combination therapies on adherence for hypertension: a meta-analysis. J Clin Hypertens (Greenwich). 2018;20(5):902\u20137.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"10","key":"2950_CR7","doi-asserted-by":"publisher","first-page":"5270","DOI":"10.1007\/s12325-021-01892-7","volume":"38","author":"F Rea","year":"2021","unstructured":"Rea F, Savar\u00e9 L, Corrao G, Mancia G. Adherence to lipid-lowering treatment by single-pill combination of statin and ezetimibe. Adv Ther. 2021;38(10):5270\u201385.","journal-title":"Adv Ther"},{"issue":"2","key":"2950_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1093\/ehjcvp\/pvaa010","volume":"7","author":"K Khalaf","year":"2021","unstructured":"Khalaf K, Johnell K, Austin PC, Tyden P, Midl\u00f6v P, Perez-Vicente R, Merlo J. Low adherence to statin treatment during the first year after acute myocardial infarction is associated with increased second-year mortality risk. Eur Heart J Cardiovasc Pharmacother. 2021;7(2):141\u20137.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"12","key":"2950_CR9","doi-asserted-by":"publisher","first-page":"e2136802","DOI":"10.1001\/jamanetworkopen.2021.36802","volume":"4","author":"W Thompson","year":"2021","unstructured":"Thompson W, Morin L, Jarb\u00f8l DE, Andersen JH, Ernst MT, Nielsen JB, Haastrup P, et al. Statin discontinuation and cardiovascular events among older people in Denmark. JAMA Netw Open. 2021;4(12):e2136802.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2950_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1093\/eurjpc\/zwac204","volume":"30","author":"RFE Pedretti","year":"2023","unstructured":"Pedretti RFE, Hansen D, Ambrosetti M, Back M, Berger T, Ferreira MC, Cornelissen V, et al. How to optimize adherence to guideline-directed medical therapy in the secondary prevention of cardiovascular diseases: a clinical consensus statement from the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2023;30(2):149\u201366.","journal-title":"Eur J Prev Cardiol"},{"issue":"34","key":"2950_CR11","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1093\/eurheartj\/ehac015","volume":"43","author":"I Byty\u00e7i","year":"2022","unstructured":"Byty\u00e7i I, Penson PE, Mikhailidis DP, Wong ND, Hernandez AV, Sahebkar A, Thompson PD, et al. Prevalence of statin intolerance: a meta-analysis. Eur Heart J. 2022;43(34):3213\u201323.","journal-title":"Eur Heart J"},{"issue":"6","key":"2950_CR12","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.3390\/jcm12062444","volume":"12","author":"G Bosco","year":"2023","unstructured":"Bosco G, Di Giacomo Barbagallo F, Spampinato S, Lanzafame L, Di Pino A, Piro S, et al. Management of statin intolerant patients in the era of novel lipid-lowering therapies: a critical approach in clinical practice. J Clin Med. 2023;12(6):2444. https:\/\/doi.org\/10.3390\/jcm12062444.","journal-title":"J Clin Med"},{"issue":"11","key":"2950_CR13","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jacc.2016.12.036","volume":"69","author":"MC Serban","year":"2017","unstructured":"Serban MC, Colantonio LD, Manthripragada AD, Monda KL, Bittner VA, Banach M, Chen L, et al. Statin intolerance and risk of coronary heart events and all-cause mortality following myocardial infarction. J Am Coll Cardiol. 2017;69(11):1386\u201395.","journal-title":"J Am Coll Cardiol"},{"key":"2950_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-024-01225-3","author":"G Bosco","year":"2024","unstructured":"Bosco G, Mszar R, Piro S, Sabouret P, Gallo A. Cardiovascular risk estimation and stratification among individuals with hypercholesterolemia. Curr Cardiol Rep. 2024. https:\/\/doi.org\/10.1007\/s11883-024-01225-3.","journal-title":"Curr Cardiol Rep"},{"key":"2950_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacl.2025.10.066","author":"A Cesaro","year":"2025","unstructured":"Cesaro A, Acerbo V, Scialla F, Zito A, Porcelli G, Panico D, et al. Reduction of visit-to-visit LDL-C intraindividual variability in patients treated with PCSK9 inhibitors and inclisiran vs standard lipid-lowering therapy. J Clin Lipidol. 2025. https:\/\/doi.org\/10.1016\/j.jacl.2025.10.066.","journal-title":"J Clin Lipidol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-026-02950-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-026-02950-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T01:59:44Z","timestamp":1782784784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12944-026-02950-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,6]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2950"],"URL":"https:\/\/doi.org\/10.1186\/s12944-026-02950-1","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,6]]},"assertion":[{"value":"21 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Dokuz Eyl\u00fcl University Ethics Committee (protocol no: 615-SBKAEK). Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"159"}}